The effects of intranasal oxytocin on black participants’ responses to outgroup acceptance and rejection

by Jiyoung Park, Joshua Woolley, Wendy Berry Mendes
Published 2022-08-01

Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians

by Amanda E. Downey, Anita V. Chaphekar, Joshua Woolley, Marissa Raymond-Flesch
Published 2024-04-01

Feasibility and preliminary efficacy of remotely delivering cognitive training to people with schizophrenia using tablets

by Bruno Biagianti, Melissa Fisher, Lisa Howard, Abby Rowlands, Sophia Vinogradov, Joshua Woolley
Published 2017-12-01

Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study

by Brian T Anderson, Alicia Danforth, Prof Robert Daroff, Christopher Stauffer, Eve Ekman, Gabrielle Agin-Liebes, Alexander Trope, Matthew Tyler Boden, Prof James Dilley, Jennifer Mitchell, Joshua Woolley
Published 2020-10-01

Towards the Development of a Pediatric Ventricular Assist Device

by Harvey S. Borovetz P.HD, Stephen Badylak, J. Robert Boston, Carl Johnson, Robert Kormos, Marina V. Kameneva, Marwan Simaan, Trevor A. Snyder, Hiro Tsukui, William R. Wagner, Joshua Woolley, James Antaki, Chenguang Diao, Stijn Vandenberghe, Bradley Keller, Victor Morell, Peter Wearden, Steven Webber, Jeff Gardiner, Chung M. Li, Dave Paden, Bradley Paden, Shaun Snyder, Jingchun Wu, Gill Bearnson, John A. Hawkins, Gordon Jacobs, John Kirk, Pratap Khanwilkar, Peter C. Kouretas, James Long, R. E. Shaddy
Published 2006-01-01